Absci Corporation
ABSI
Cena:
$ 5.10
+0.01 (0.20%)
Valuace
70
Růst
0
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
ABSCI TO PARTICIPATE IN THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
16-12-2025
VANCOUVER, WASH. AND NEW YORK, DEC. 16, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), A...
Více zde
ABSCI REPORTS NEW HUMAN EX VIVO DATA DEMONSTRATING THAT ABS-201™ STIMULATES HAIR GROWTH AND REGENERATES STEM CELL NICHE TO POTENTIALLY REVERSE FOLLICLE MINIATURIZATION
11-12-2025
INHIBITING PROLACTIN RECEPTOR (PRLR) SIGNALING WITH THE ABS-201 ANTI-PRLR ANTIBODY PROMOTES HUMAN HA...
Více zde
ABSCI AND U.S. SOCCER LEGEND LANDON DONOVAN PARTNER TO CHAMPION THE PATIENT VOICE IN HAIR LOSS RESEARCH
10-12-2025
PARTNERSHIP AIMS TO DESTIGMATIZE ANDROGENETIC ALOPECIA AND HIGHLIGHT THE NEED FOR NEW THERAPEUTIC OP...
Více zde
ABSCI ANNOUNCES FIRST PARTICIPANTS DOSED IN PHASE 1/2A HEADLINE™ TRIAL OF AI-DESIGNED ANTIBODY ABS-201™ FOR ANDROGENETIC ALOPECIA
04-12-2025
STUDY TO EVALUATE SAFETY AND EFFICACY OF NOVEL ANTI-PRLR ANTIBODY; INTERIM DATA ANTICIPATED IN THE S...
Více zde
ABSCI REPORTS BUSINESS UPDATES AND THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS
12-11-2025
REPORTED INTERIM RESULTS FOR PHASE 1 TRIAL FOR ABS-101 (ANTI-TL1A) ON TRACK TO INITIATE PH1/2A TRIAL...
Více zde
ABSCI TO REPORT BUSINESS UPDATES AND THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS ON NOVEMBER 12, 2025
29-10-2025
VANCOUVER, WASH. AND NEW YORK, OCT. 29, 2025 (GLOBE NEWSWIRE) -- ABSCI (NASDAQ: ABSI), A CLINICAL-ST...
Více zde
ABSCI TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
27-10-2025
VANCOUVER, WASH. AND NEW YORK, OCT. 27, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), A...
Více zde
ABSCI TO HOST KOL SEMINAR ON ABS-201 ANDROGENETIC ALOPECIA PROGRAM ON DECEMBER 11, 2025; ANNOUNCES ACCELERATED INITIATION OF PHASE 1/2A TRIAL
15-10-2025
WEBINAR ON DECEMBER 11 TO FEATURE LEADING KOLS IN DERMATOLOGY AND HAIR LOSS ALONGSIDE ABSCI LEADERSH...
Více zde
ABSCI ACCELERATES AI-DRIVEN DRUG DISCOVERY WITH ORACLE AND AMD
11-09-2025
PERFORMANCE AND SCALABILITY OF ORACLE CLOUD INFRASTRUCTURE AI INFRASTRUCTURE ENABLES ABSCI TO ACCELE...
Více zde
ABSCI EXPANDS ABS-201 SCIENTIFIC ADVISORY BOARD WITH ADDITION OF LEADING DERMATOLOGY EXPERTS DR. RODNEY SINCLAIR AND DR. DAVID GOLDBERG
25-08-2025
WORLD-RENOWNED EXPERTS WILL GUIDE THE CLINICAL DEVELOPMENT OF ABS-201, A THERAPEUTIC ANTIBODY ENTERI...
Více zde
ABSCI TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
20-08-2025
VANCOUVER, WASH. AND NEW YORK, AUG. 20, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), A...
Více zde
ABSCI REPORTS BUSINESS UPDATES AND SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTS
12-08-2025
STRENGTHENED BALANCE SHEET RAISING APPROXIMATELY $64 MILLION IN GROSS PROCEEDS IN JULY 2025; CASH, C...
Více zde
ALMIRALL AND ABSCI EXPAND AI DRUG CREATION COLLABORATION ADDING A SECOND DERMATOLOGY TARGET
07-08-2025
BARCELONA, SPAIN AND VANCOUVER, WASH., AUG. 07, 2025 (GLOBE NEWSWIRE) -- ALMIRALL (BME: ALM), A GLOB...
Více zde
ABSCI TO REPORT BUSINESS UPDATES AND SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTS ON AUGUST 12, 2025
30-07-2025
VANCOUVER, WASH. AND NEW YORK, JULY 30, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), A...
Více zde
ABSCI ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
24-07-2025
VANCOUVER, WASH., JULY 24, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI) (“ABSCI”), ...
Více zde
ABSCI ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
24-07-2025
VANCOUVER, WASH., JULY 24, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI) (“ABSCI”), ...
Více zde
ABSCI APPOINTS BIOPHARMA LEADER MARY SZELA TO BOARD OF DIRECTORS
07-07-2025
VANCOUVER, WASH., JULY 07, 2025 (GLOBE NEWSWIRE) -- ABSCI (NASDAQ: ABSI), A CLINICAL-STAGE BIOPHARMA...
Více zde
ABSCI TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
20-05-2025
VANCOUVER, WASH. AND NEW YORK, MAY 20, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), A ...
Více zde
ABSCI REPORTS BUSINESS UPDATES AND FIRST QUARTER 2025 FINANCIAL AND OPERATING RESULTS
13-05-2025
INITIATED DOSING OF PARTICIPANTS IN THE FIRST-IN-HUMAN STUDY OF ABS-101 (ANTI-TL1A ANTIBODY), WITH I...
Více zde
ABSCI ANNOUNCES FIRST PARTICIPANTS DOSED IN PHASE 1 CLINICAL TRIAL OF ABS-101, A POTENTIAL BEST-IN-CLASS ANTI-TL1A ANTIBODY FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
13-05-2025
ABSCI BECOMES CLINICAL STAGE COMPANY WITH ABS-101, FIRST AI-DESIGNED BIOLOGIC FOR IBD, BEGINNING PHA...
Více zde
ABSCI TO REPORT BUSINESS UPDATES AND FIRST QUARTER 2025 FINANCIAL AND OPERATING RESULTS ON MAY 13, 2025
14-04-2025
VANCOUVER, WASH. AND NEW YORK, APRIL 14, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), ...
Více zde
ABSCI TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
26-03-2025
VANCOUVER, WASH. AND NEW YORK, MARCH 26, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), ...
Více zde
ABSCI REPORTS BUSINESS UPDATES AND FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL AND OPERATING RESULTS
18-03-2025
UNVEILED UPDATES ACROSS PROPRIETARY PIPELINE AND DEMONSTRATED NEW BREAKTHROUGHS BY AI PLATFORM AT 20...
Více zde
ABSCI TO REPORT BUSINESS UPDATES AND FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL AND OPERATING RESULTS ON MARCH 18, 2025
04-03-2025
VANCOUVER, WASH. AND NEW YORK, MARCH 04, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), ...
Více zde
ABSCI ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
04-03-2025
VANCOUVER, WASH. AND NEW YORK, MARCH 04, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), ...
Více zde
ABSCI TO PARTICIPATE IN THE KEYBANC CAPITAL MARKETS HEALTHCARE FORUM
04-03-2025
VANCOUVER, WASH. AND NEW YORK, MARCH 04, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), ...
Více zde
ABSCI TO PARTICIPATE IN THE TD COWEN 45TH ANNUAL HEALTH CARE CONFERENCE
18-02-2025
VANCOUVER, WASH. AND NEW YORK, FEB. 18, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), A...
Více zde
ABSCI TO PARTICIPATE IN THE GUGGENHEIM SECURITIES SMID CAP BIOTECH CONFERENCE
22-01-2025
VANCOUVER, WASH. AND NEW YORK, JAN. 22, 2025 (GLOBE NEWSWIRE) -- ABSCI CORPORATION (NASDAQ: ABSI), A...
Více zde
ABSCI AND OWKIN SYNERGIZE LEADING TECHBIO PLATFORMS TO ADVANCE GENERATIVE AI DRUG DISCOVERY
10-01-2025
COLLABORATION COMBINES OWKIN'S NOVEL AI TARGET DISCOVERY AND AGENTIC AI EXPERTISE WITH ABSCI'S LEADI...
Více zde
ABSCI AND AMD ANNOUNCE COLLABORATION AND STRATEGIC INVESTMENT TO ACCELERATE THE FUTURE OF AI DRUG DISCOVERY
08-01-2025
$20 MILLION EQUITY INVESTMENT FROM AMD STRENGTHENS ABSCI'S LEADERSHIP IN AI DRUG DISCOVERY AND FURTH...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-01-14 00:00:00 | 8-K | Stáhnout | |
| 2025-11-12 00:00:00 | 8-K | Stáhnout | |
| 2025-11-12 00:00:00 | 10-Q | Stáhnout | |
| 2025-11-04 00:00:00 | 8-K | Stáhnout | |
| 2025-08-12 01:00:00 | 8-K | Stáhnout | |
| 2025-08-12 01:00:00 | 10-Q | Stáhnout | |
| 2025-08-12 00:00:00 | 8-K | Stáhnout | |
| 2025-08-12 00:00:00 | 10-Q | Stáhnout | |
| 2025-07-25 01:00:00 | 8-K | Stáhnout | |
| 2025-07-25 00:00:00 | 8-K | Stáhnout | |
| 2025-07-08 01:00:00 | 8-K | Stáhnout | |
| 2025-07-08 00:00:00 | 8-K | Stáhnout | |
| 2025-06-12 01:00:00 | 8-K | Stáhnout | |
| 2025-06-12 00:00:00 | 8-K | Stáhnout | |
| 2025-05-13 01:00:00 | 8-K | Stáhnout | |
| 2025-05-13 01:00:00 | 10-Q | Stáhnout | |
| 2025-05-13 00:00:00 | 8-K | Stáhnout | |
| 2025-05-13 00:00:00 | 10-Q | Stáhnout | |
| 2025-04-28 01:00:00 | 8-K | Stáhnout | |
| 2025-04-28 00:00:00 | 8-K | Stáhnout | |
| 2025-03-18 00:00:00 | 8-K | Stáhnout | |
| 2025-03-18 00:00:00 | 10-K | Stáhnout | |
| 2025-03-17 23:00:00 | 8-K | Stáhnout | |
| 2025-03-17 23:00:00 | 10-K | Stáhnout | |
| 2025-01-15 00:00:00 | 8-K | Stáhnout | |
| 2025-01-14 23:00:00 | 8-K | Stáhnout | |
| 2024-11-12 00:00:00 | 8-K | Stáhnout | |
| 2024-11-11 23:00:00 | 8-K | Stáhnout | |
| 2024-09-04 01:00:00 | 8-K | Stáhnout | |
| 2024-09-04 00:00:00 | 8-K | Stáhnout | |
| 2024-08-14 01:00:00 | 8-K | Stáhnout | |
| 2024-08-14 01:00:00 | 10-Q | Stáhnout | |
| 2024-08-14 00:00:00 | 8-K | Stáhnout | |
| 2024-08-14 00:00:00 | 10-Q | Stáhnout | |
| 2024-06-14 01:00:00 | 8-K | Stáhnout | |
| 2024-06-14 00:00:00 | 8-K | Stáhnout | |
| 2024-05-14 01:00:00 | 8-K | Stáhnout | |
| 2024-05-14 01:00:00 | 10-Q | Stáhnout | |
| 2024-05-14 00:00:00 | 8-K | Stáhnout | |
| 2024-05-14 00:00:00 | 10-Q | Stáhnout | |
| 2024-03-21 00:00:00 | 8-K | Stáhnout | |
| 2024-03-21 00:00:00 | 10-K | Stáhnout | |
| 2024-03-20 23:00:00 | 8-K | Stáhnout | |
| 2024-03-20 23:00:00 | 10-K | Stáhnout | |
| 2024-02-28 00:00:00 | 8-K | Stáhnout | |
| 2024-02-27 23:00:00 | 8-K | Stáhnout | |
| 2024-02-27 00:00:00 | 8-K | Stáhnout | |
| 2024-02-26 23:00:00 | 8-K | Stáhnout | |
| 2024-01-08 00:00:00 | 8-K | Stáhnout | |
| 2024-01-07 23:00:00 | 8-K | Stáhnout | |
| 2023-12-20 00:00:00 | 8-K | Stáhnout | |
| 2023-12-19 23:00:00 | 8-K | Stáhnout | |
| 2023-12-07 00:00:00 | 8-K | Stáhnout | |
| 2023-12-06 23:00:00 | 8-K | Stáhnout | |
| 2023-12-04 00:00:00 | 8-K | Stáhnout | |
| 2023-12-03 23:00:00 | 8-K | Stáhnout | |
| 2023-11-14 00:00:00 | 8-K | Stáhnout | |
| 2023-11-14 00:00:00 | 10-Q | Stáhnout | |
| 2023-11-13 23:00:00 | 8-K | Stáhnout | |
| 2023-11-13 23:00:00 | 10-Q | Stáhnout | |
| 2023-09-05 01:00:00 | 8-K | Stáhnout | |
| 2023-09-05 00:00:00 | 8-K | Stáhnout | |
| 2023-08-17 01:00:00 | 8-K | Stáhnout | |
| 2023-08-17 00:00:00 | 8-K | Stáhnout | |
| 2023-08-14 01:00:00 | 8-K | Stáhnout | |
| 2023-08-14 01:00:00 | 10-Q | Stáhnout | |
| 2023-08-14 00:00:00 | 8-K | Stáhnout | |
| 2023-08-14 00:00:00 | 10-Q | Stáhnout | |
| 2023-06-16 01:00:00 | 8-K | Stáhnout | |
| 2023-06-16 00:00:00 | 8-K | Stáhnout | |
| 2023-06-06 01:00:00 | 8-K | Stáhnout | |
| 2023-06-06 00:00:00 | 8-K | Stáhnout | |
| 2023-05-15 01:00:00 | 8-K | Stáhnout | |
| 2023-05-15 01:00:00 | 10-Q | Stáhnout | |
| 2023-05-15 00:00:00 | 8-K | Stáhnout | |
| 2023-05-15 00:00:00 | 10-Q | Stáhnout | |
| 2023-03-30 01:00:00 | 8-K | Stáhnout | |
| 2023-03-30 01:00:00 | 10-K | Stáhnout | |
| 2023-03-30 00:00:00 | 8-K | Stáhnout | |
| 2023-03-30 00:00:00 | 10-K | Stáhnout | |
| 2023-03-10 00:00:00 | 8-K | Stáhnout | |
| 2023-03-09 23:00:00 | 8-K | Stáhnout | |
| 2022-12-16 00:00:00 | 8-K | Stáhnout | |
| 2022-12-15 23:00:00 | 8-K | Stáhnout | |
| 2022-11-09 00:00:00 | 8-K | Stáhnout | |
| 2022-11-09 00:00:00 | 10-Q | Stáhnout | |
| 2022-11-08 23:00:00 | 8-K | Stáhnout | |
| 2022-11-08 23:00:00 | 10-Q | Stáhnout | |
| 2022-11-02 00:00:00 | 8-K | Stáhnout | |
| 2022-11-01 23:00:00 | 8-K | Stáhnout | |
| 2022-10-04 01:00:00 | 8-K | Stáhnout | |
| 2022-10-04 00:00:00 | 8-K | Stáhnout | |
| 2022-09-20 01:00:00 | 8-K | Stáhnout | |
| 2022-09-20 00:00:00 | 8-K | Stáhnout | |
| 2022-08-11 01:00:00 | 8-K | Stáhnout | |
| 2022-08-11 01:00:00 | 10-Q | Stáhnout | |
| 2022-08-11 00:00:00 | 8-K | Stáhnout | |
| 2022-08-11 00:00:00 | 10-Q | Stáhnout | |
| 2022-07-14 01:00:00 | 8-K | Stáhnout | |
| 2022-07-14 00:00:00 | 8-K | Stáhnout | |
| 2022-06-10 01:00:00 | 8-K | Stáhnout | |
| 2022-06-10 00:00:00 | 8-K | Stáhnout | |
| 2022-05-11 01:00:00 | 8-K | Stáhnout | |
| 2022-05-11 01:00:00 | 10-Q | Stáhnout | |
| 2022-05-11 00:00:00 | 8-K | Stáhnout | |
| 2022-05-11 00:00:00 | 10-Q | Stáhnout | |
| 2022-03-22 00:00:00 | 8-K | Stáhnout | |
| 2022-03-22 00:00:00 | 10-K | Stáhnout | |
| 2022-03-21 23:00:00 | 8-K | Stáhnout | |
| 2022-03-21 23:00:00 | 10-K | Stáhnout | |
| 2022-03-21 00:00:00 | 8-K | Stáhnout | |
| 2022-03-20 23:00:00 | 8-K | Stáhnout | |
| 2022-01-10 00:00:00 | 8-K | Stáhnout | |
| 2022-01-09 23:00:00 | 8-K | Stáhnout | |
| 2022-01-07 00:00:00 | 8-K | Stáhnout | |
| 2022-01-06 23:00:00 | 8-K | Stáhnout | |
| 2021-11-09 00:00:00 | 8-K | Stáhnout | |
| 2021-11-09 00:00:00 | 10-Q | Stáhnout | |
| 2021-11-08 23:00:00 | 8-K | Stáhnout | |
| 2021-11-08 23:00:00 | 10-Q | Stáhnout | |
| 2021-09-07 01:00:00 | 8-K | Stáhnout | |
| 2021-09-07 01:00:00 | 10-Q | Stáhnout | |
| 2021-09-07 00:00:00 | 8-K | Stáhnout | |
| 2021-09-07 00:00:00 | 10-Q | Stáhnout | |
| 2021-08-24 01:00:00 | 8-K | Stáhnout | |
| 2021-08-24 00:00:00 | 8-K | Stáhnout | |
| 2021-07-26 01:00:00 | 8-K | Stáhnout | |
| 2021-07-26 00:00:00 | 8-K | Stáhnout |
